Document 0768
 DOCN  M9590768
 TI    [The calculation of AIDS costs in Spain by simulation technics (see
       comments)]
 DT    9509
 AU    Antonanzas Villar F; Anton Botella F; Juarez Castello C; Departamento de
       Economia y Empresa, Universidad de La Rioja,; Logrono.
 SO    Med Clin (Barc). 1995 Apr 22;104(15):568-72. Unique Identifier :
       AIDSLINE MED/95287671
 CM    Comment in: Med Clin (Barc) 1995 Apr 22;104(15):573-5
 AB    BACKGROUND: The aim of this study was to elaborate a quantitative model
       integrating the clinical, and epidemiologic characteristics of the
       economic costs of the treatment of HIV infected and AIDS patients in
       Spain to determine the future evolution of the treatment of HIV infected
       and AIDS patients in Spain to determine the future evolution of the
       disease and predict the costs of the treatments for the Spanish health
       care system in 1995. METHODS: A model based on the calculation of
       probabilities in which the classification of AIDS patients was designed
       in three phases: early, intermediate and AIDS and established the
       relations of changes among the phases and included the economic costs of
       each of the treatments. The model was programmed on a calculation sheet
       to allow possibilities of disease evolution to be configured in addition
       to the costs. RESULTS: In 1995 the health care system will treat 22,000
       AIDS patients together with those with HIV infection leading to three
       million hospital stays, equivalent to 8,000 hospital beds dedicated to
       each treatments with a budget repercussion of close to 90,000 million
       pesetas. The number of consultations to specialists will increase to up
       to 570,000 with the total cost of health care treatments being up to
       113,000 million pesetas. CONCLUSIONS: The results of this model indicate
       high health care costs derived from the treatment of AIDS and HIV
       infection. Given the fact that it is possible to perform simulations
       with the model under other hypothesis, basic clinical, epidemiologic and
       economic data are required to determine the most realistic possibilities
       to thereby orient global policies concerning this disease.
 DE    Acquired Immunodeficiency Syndrome/CLASSIFICATION/*ECONOMICS/
       EPIDEMIOLOGY/THERAPY  Costs and Cost Analysis  English Abstract  Female
       Forecasting  Hospitalization/ECONOMICS/STATISTICS & NUMER DATA  Human
       HIV Infections/CLASSIFICATION/ECONOMICS/EPIDEMIOLOGY/THERAPY  *HIV-1
       Incidence  Male  *Models, Economic  Probability  Referral and
       Consultation/ECONOMICS/STATISTICS & NUMER DATA  Spain/EPIDEMIOLOGY
       JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).